Economy

US approves F-16 fighter jet sales to Turkey and Greece: State Department

Published

Join Fox News for access to this content
Plus get unlimited access to thousands of articles, videos and more with your free account!
Please enter a valid email address.
By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your email and follow the instructions provided.

The State Department on Friday approved the sale of dozens of new fighter jets to both Turkey and Greece.

According to the Defense Security Cooperation Agency, the State Department has agreed to sell 40 new F16 jets to Turkey. 

The agency has also agreed to sell Turkey’s neighbor, Greece, 40 F-35 Joint Strike Fighter aircraft.

Congress was notified of the sale today, the Defense Security Cooperation Agency.

Turkey will also make upgrades to 79 of its existing fleet.

The cost for Turkey is estimated to be valued at up to $23B, the agency said.

Greece’s purchase is valued at up to $8.6B.

This post appeared first on FOX NEWS
In this article:

You May Also Like

Investing

Silver Price Update: Q1 2024 in Review

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

April 24, 2024

Latest News

Two key military appointments from China’s naval ranks reflects Xi’s territorial ambitions, analysts say

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

January 3, 2024

Investing

3 Biggest US Silver Miners in 2024

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

May 30, 2024

Investing

Canadian Pharma Stocks: 5 Biggest Companies in 2024

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

May 9, 2024

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 GreatWallStreetPublisher.com

Exit mobile version